GlassScriptPhysician profile
Sankar Varanasi
NPI 1073586988
$12,232.36
in general payments reported to CMS, 2019-2025
15 companies · $7,313 in 2025
The $7,313 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $29.48 · 2021: $38.80 · 2022: $912 · 2023: $1,828 · 2024: $1,488 · 2025: $7,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,479 · Food and Beverage: $4,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,479.02 |
| Food and Beverage | $4,150.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $3,934.04 | 2019-2025 | Carto 3, Qdot Micro Catheter, Soundstar |
| Medtronic, INC. | $3,255.18 | 2023-2025 | Micra, Evera Mri Xt Dr Surescan, Open Pivot |
| Abbott Laboratories | $2,265.10 | 2019-2025 | Ensite, Aveir |
| Medical Device Business Services, INC. | $988.07 | 2022-2024 | Carto 3 |
| Abiomed | $598.65 | 2024-2025 | Impella |
| Boston Scientific Corporation | $357.22 | 2019-2024 | Watchman, Watchman Flx |
| Impulse Dynamics (USA) INC. | $292.63 | 2022-2025 | Optimizer, Optimizer |
| Stereotaxis INC | $160.41 | 2019-2021 | |
| Irhythm Technologies, INC. | $123.36 | 2023 | Zio Xt Patch |
| Edwards Lifesciences Corporation | $77.99 | 2019 | |
| Cvrx, INC. | $71.45 | 2023 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $71.41 | 2019-2024 | |
| Cardiovascular Systems INC. | $24.71 | 2019 | |
| Cardinal Health 200 LLC | $12.14 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sankar Varanasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.